Cargando…

Yersiniosis in New Zealand

The rate of yersiniosis in New Zealand (NZ) is high compared with other developed countries, and rates have been increasing over recent years. Typically, >99% of human cases in NZ are attributed to Yersinia enterocolitica (YE), although in 2014, a large outbreak of 220 cases was caused by Yersini...

Descripción completa

Detalles Bibliográficos
Autores principales: Rivas, Lucia, Strydom, Hugo, Paine, Shevaun, Wang, Jing, Wright, Jackie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916520/
https://www.ncbi.nlm.nih.gov/pubmed/33578727
http://dx.doi.org/10.3390/pathogens10020191
_version_ 1783657495992991744
author Rivas, Lucia
Strydom, Hugo
Paine, Shevaun
Wang, Jing
Wright, Jackie
author_facet Rivas, Lucia
Strydom, Hugo
Paine, Shevaun
Wang, Jing
Wright, Jackie
author_sort Rivas, Lucia
collection PubMed
description The rate of yersiniosis in New Zealand (NZ) is high compared with other developed countries, and rates have been increasing over recent years. Typically, >99% of human cases in NZ are attributed to Yersinia enterocolitica (YE), although in 2014, a large outbreak of 220 cases was caused by Yersinia pseudotuberculosis. Up until 2012, the most common NZ strain was YE biotype 4. The emergent strain since this time is YE biotype 2/3 serotype O:9. The pathogenic potential of some YE biotypes remains unclear. Most human cases of yersiniosis are considered sporadic without an identifiable source. Key restrictions in previous investigations included insufficient sensitivity for the isolation of Yersinia spp. from foods, although foodborne transmission is the most likely route of infection. In NZ, YE has been isolated from a variety of sick and healthy domestic and farm animals but the pathways from zoonotic reservoir to human remain unproven. Whole-genome sequencing provides unprecedented discriminatory power for typing Yersinia and is now being applied to NZ epidemiological investigations. A “One-Health” approach is necessary to elucidate the routes of transmission of Yersinia and consequently inform targeted interventions for the prevention and management of yersiniosis in NZ
format Online
Article
Text
id pubmed-7916520
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-79165202021-03-01 Yersiniosis in New Zealand Rivas, Lucia Strydom, Hugo Paine, Shevaun Wang, Jing Wright, Jackie Pathogens Review The rate of yersiniosis in New Zealand (NZ) is high compared with other developed countries, and rates have been increasing over recent years. Typically, >99% of human cases in NZ are attributed to Yersinia enterocolitica (YE), although in 2014, a large outbreak of 220 cases was caused by Yersinia pseudotuberculosis. Up until 2012, the most common NZ strain was YE biotype 4. The emergent strain since this time is YE biotype 2/3 serotype O:9. The pathogenic potential of some YE biotypes remains unclear. Most human cases of yersiniosis are considered sporadic without an identifiable source. Key restrictions in previous investigations included insufficient sensitivity for the isolation of Yersinia spp. from foods, although foodborne transmission is the most likely route of infection. In NZ, YE has been isolated from a variety of sick and healthy domestic and farm animals but the pathways from zoonotic reservoir to human remain unproven. Whole-genome sequencing provides unprecedented discriminatory power for typing Yersinia and is now being applied to NZ epidemiological investigations. A “One-Health” approach is necessary to elucidate the routes of transmission of Yersinia and consequently inform targeted interventions for the prevention and management of yersiniosis in NZ MDPI 2021-02-10 /pmc/articles/PMC7916520/ /pubmed/33578727 http://dx.doi.org/10.3390/pathogens10020191 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Rivas, Lucia
Strydom, Hugo
Paine, Shevaun
Wang, Jing
Wright, Jackie
Yersiniosis in New Zealand
title Yersiniosis in New Zealand
title_full Yersiniosis in New Zealand
title_fullStr Yersiniosis in New Zealand
title_full_unstemmed Yersiniosis in New Zealand
title_short Yersiniosis in New Zealand
title_sort yersiniosis in new zealand
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916520/
https://www.ncbi.nlm.nih.gov/pubmed/33578727
http://dx.doi.org/10.3390/pathogens10020191
work_keys_str_mv AT rivaslucia yersiniosisinnewzealand
AT strydomhugo yersiniosisinnewzealand
AT paineshevaun yersiniosisinnewzealand
AT wangjing yersiniosisinnewzealand
AT wrightjackie yersiniosisinnewzealand